Sara S. Samimi, MD
Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
View 1 additional location
Schedule onlineCall 215-662-2737
Headshot of Sara S. Samimi, MD
Penn Medicine Provider

About me

  • Associate Program Director
  • Vice Chair of Quality and Safety
  • Professor of Clinical Dermatology

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Pennsylvania Hospital
  • Residency: University of Pennsylvania Health System

What my patients think about me

Average Rating

816 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

February 2026
she is the best!!!
February 2026
very satisfied with care provided.
February 2026
thorough
February 2026
simply the best!

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Samimi is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Tuohy S, Wachuku C, Wang YA, Prasad A, Samimi SS, Pappas-Taffer LK, Haun PL, Wang LL Cutaneous mantle cell lymphoma presenting as a diffuse morbilliform rash: A case report , SAGE Open Med Case Rep: 2023

Marsch A, Khodosh R, Porter M, Raad J, Samimi S, Schultz B, Chaney Strowd L, Vera L, Wong E, Smith GP Implementing Patient Safety and Quality Improvement in Dermatology Part 2: Quality Improvement Science , J Am Acad Dermatol, 89(4): 2023,657-67

Marsch A, Khodosh R, Porter M, Raad J, Samimi S, Schultz B, Chaney Strowd L, Vera L, Wong E, Smith GP Implementing Patient Safety and Quality Improvement in Dermatology Part 1: Patient Safety Science , J Am Acad Dermatol, 89(4): 2023,641-54

Himeless JR, Holton J, Vittorio C, Rook A, Haun P, Villasenor-Park J, Samimi S, Kim E Recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T Cell Lymphoma , JAMA Dermatol, 88(3): 2023,680-83

Wanat KA, Perelygina L, Chen MH, Hao L, Abernathy E, Bender NR, Shields BE, Wilson BDE, Crosby D, Routes J, Samimi SS, Haun PL, Sokumbi O, Icenogle JP, Sullivan KE, Rosenbach M, Drolet BA Association of persistent rubella virus with idiopathic skin granulomas in clinically immunocompetent adults , JAMA Dermatol, 158(6): 2022,626-33

Weiner DM, Clark AK, Bhansali R, Pappas-Taffer L, Barta SK, Villasenor-Park J, Haun PL, Vittorio CC, Rook AH, Kim EJ, Samimi SS Usage and Safety of Topical Tacrolimus in Patients with Mycosis Fungoides , Clin Exp Dermatol, 47(6): 2022,1200-01

Samimi S, Choi J, Rosman IS, Rosenbach M Impact of COVID-19 on Dermatology Residency , Dermatol Clin, 39(4): 2021,609-18

Weiner DM, Clark AK, Moon AT, Haun PL, Samimi SS A case of nevoid follicular mucinosis in a child , JAAD Case Rep, 18: 2021,29-32

Shields B, Perelygina L, Samimi S, Haun P, Leung T, Abernathy E, Chen M, Hao L, Icenogle J, Drolet B, Wilson B, Bryer J, England R, Blumberg E, Wanat K, Sullivan K, Rosenbach M Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency , JAMA Dermatol, 157(7): 2021,842-47

Lewis D, Haun P, Samimi S, Vittorio C, Villasenor-Park J, Barta S, Landsburg D, Svoboda J, Nasta S, Schuster S, Rook A, Kim E Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome , JAMA Dermatol, 157(3): 2021,317-21